Design Therapeutics, Inc. (DSGN)
15.55
+1.33
(+9.35%)
USD |
NASDAQ |
May 11, 16:00
15.55
0.00 (0.00%)
After-Hours: 18:52
Design Therapeutics Total Liabilities (Quarterly) : 12.39M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| vTv Therapeutics, Inc. | 25.46M |
| Immuneering Corp. | 13.50M |
| X4 Pharmaceuticals, Inc. | 101.83M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 230.44M |
| Shareholders Equity (Quarterly) | 218.05M |
| Debt to Equity Ratio | 0.0125 |
| Current Ratio | 22.28 |
| Net Debt Paydown Yield | -0.01% |